11.11.2015 - The US Food and Drug Administration (FDA) has approved Gilead Sciences’ Genvoya to treat HIV-1 infection. Genvoya combines four treatments – elvitegravir, cobicistat, emtricitabine...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)